Inventor · disambiguated record
Stephanie Grosse
Also filed as: GROSSE STEPHANIE · GROSSE STÉPHANIE
11 granted patents·7 pending applications·40 citations·filing 2007–2023
90Inventor score
Top patents by PatentIndex Score
18 records- 0195US10286007B2Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cellsCELLECTIS·Filed 2017·Granted May 14, 2019·12 cites·18 claims
- 0294US11274316B2Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cellsCELLECTIS·Filed 2021·Granted Mar 15, 2022·2 cites·5 claims
- 0391US10363270B2Methods for engineering allogeneic and immunosuppressive resistant T cell immunotherapyCELLECTIS·Filed 2017·Granted Jul 30, 2019·6 cites·7 claims
- 0490US10426795B2Use of preTalpha or functional variant thereof for expanding TCRalpha deficient T cellsCELLECTIS·Filed 2013·Granted Oct 1, 2019·8 cites·17 claims
- 0589US2024309397A1Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapyCELLECTIS·Filed 2023·Application pending·0 cites
- 0687US11304975B2Methods for engineering allogeneic and highly active t cell for immunotherapyCELLECTIS·Filed 2014·Granted Apr 19, 2022·4 cites·6 claims
- 0786US11891614B2Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapyCELLECTIS·Filed 2020·Granted Feb 6, 2024·1 cites·16 claims
- 0886US10517896B2Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cellsCELLECTIS·Filed 2019·Granted Dec 31, 2019·2 cites·19 claims
- 0982US2022177914A1Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cellsCELLECTIS·Filed 2022·Application pending·0 cites
- 1079US11414674B2Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cellsCELLECTIS·Filed 2019·Granted Aug 16, 2022·0 cites·10 claims
- 1177US11311575B2Methods for engineering highly active T cell for immunotherapyCELLECTIS·Filed 2014·Granted Apr 26, 2022·1 cites·15 claims
- 1274US9399016B2Materials and complexes for the delivery of biologically-active materials to cellsHART STEPHEN LEWIS·Filed 2007·Granted Jul 26, 2016·4 cites·14 claims
- 1372US11603539B2Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapyCELLECTIS·Filed 2013·Granted Mar 14, 2023·0 cites·9 claims
- 1470US2023201260A1Methods for engineering allogeneic and highly active t cell for immunotheraphyCELLECTIS·Filed 2022·Application pending·0 cites
- 1570US2018360883A1Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapyCELLECTIS·Filed 2018·Application pending·0 cites
- 1667US2023050345A1Methods for engineering allogeneic and highly active t cell for immunotheraphyCELLECTIS·Filed 2022·Application pending·0 cites
- 1760US2023056268A1Methods for engineering highly active t cell for immunotheraphyCELLECTIS·Filed 2022·Application pending·0 cites
- 1850US2015017136A1Methods for engineering allogeneic and highly active t cell for immunotherapyCELLECTIS·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephanie Grosse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →